Post-approval studies (Phase 4)Looking for participantsNCT05916937
What this trial is testing
Extending Omalizumab Treatment Intervals in Patients With Chronic Spontaneous Urticaria
Who this might be right for
Chronic Spontaneous UrticariaChronic Urticaria, Idiopathic
Simon Francis Thomsen 40